SPARC and obesity due to melanocortin 4 receptor deficiency: Among SPARC’s properties that could lead to possible therapeutic applications, we have anti-inflammatory [80], anti-ageing [78,79], anti-sarcopenia/muscle atrophy [81] and anti-obesity properties [82], as well as SPARC’s importance for immunity [83].